Borrowings (Tables)	12 Months Ended
	Dec. 31, 2021
Borrowings [Abstract]
Summary Of Borrowings	As of December 31, 2021(Dollars in thousands) Maturity Date Contractual‎Facility Balance,‎Gross Balance,‎Net(1) Stated‎Interest‎Rate Effective‎Interest‎RateDenominated in USD Trust Preferred Securities (US) April 30, 2027 $ 27,913  $ 27,913  $ 26,728  4.13% 4.13%Bank of America Credit Facility (US) March 6, 2023 39,500  39,500  39,364  5.75% 5.75%Cinemas 1, 2, 3 Term Loan (US) April 1, 2022 24,039  24,039  23,680  4.25% 4.25%Minetta & Orpheum Theatres Loan (US)(2) November 1, 2023 8,000  8,000  7,944  2.14% 5.15%U.S. Corporate Office Term Loan (US) January 1, 2027 8,936  8,936  8,860  4.64% / 4.44% 4.64%Union Square Financing (US) May 6, 2024 55,000  43,000  42,002  7.00% 7.00%Purchase Money Promissory Note (US) September 18, 2024 2,043  2,043  2,043  5.00% 5.00%Denominated in foreign currency ("FC")(3) NAB Corporate Term Loan (AU) December 31, 2023 74,052 74,052  73,900  1.82% 1.82%Westpac Bank Corporate (NZ) December 31, 2023 9,465  9,465  9,465  3.45% 3.45%Total $ 248,948 $ 236,948  $ 233,986  (1)Net of deferred financing costs amounting to $3.0 million.(2)The interest rate derivative associated with the Minetta & Orpheum loan provides for an effective fixed rate of 5.15%.(3)The contractual facilities and outstanding balances of the FC-denominated borrowings were translated into U.S. dollars based on exchange rates as of December 31, 2021. As of December 31, 2020(Dollars in thousands) Maturity Date Contractual‎Facility Balance,‎Gross Balance,‎Net(1) Stated‎Interest‎Rate Effective‎Interest‎RateDenominated in USD Trust Preferred Securities (US) April 30, 2027 $ 27,913  $ 27,913  $ 26,505 4.27% 4.27%Bank of America Credit Facility (US) March 6, 2023 55,000  51,200 50,990 4.00% 4.00%Bank of America Line of Credit (US) March 6, 2023 5,000  5,000 5,000 3.15% 3.15%Cinemas 1, 2, 3 Term Loan (US) April 1, 2022 24,625 24,625 24,248 4.25% 4.25%Minetta & Orpheum Theatres Loan (US)(2) November 1, 2023 8,000 8,000 7,914 2.20% 5.15%U.S. Corporate Office Term Loan (US) January 1, 2027 9,186 9,186 9,095 4.64% / 4.44% 4.64%Union Square Financing (US) March 31, 2021 50,000 40,623 40,620 17.50% 17.50%Purchase Money Promissory Note September 18, 2024 2,883 2,883 2,883 5.00% 5.00%Denominated in foreign currency ("FC")(3) NAB Corporate Term Loan (AU) December 31, 2023 94,821 92,508 92,307 1.81% 1.81%Westpac Bank Corporate (NZ) December 31, 2023 23,021 23,021 23,021 2.95% 2.95%Total $ 300,449 $ 284,959 $ 282,583 (1)Net of deferred financing costs amounting to $2.2 million.(2)The interest rate derivative associated with the Minetta & Orpheum loan provides for an effective fixed rate of 5.15%.(3)The contractual facilities and outstanding balances of the FC-denominated borrowings were translated into U.S. dollar based on exchange rates as of December 31, 2020.
Schedule Of Long-term Debt Instruments, Net Of The Deferred Financing Costs	(Dollars in thousands) December 31,Balance Sheet Caption 2021 2020Debt - current portion $ 11,349 $ 41,459Debt - long-term portion 195,198 213,779Subordinated debt - current portion 711 840Subordinated debt - long-term portion 26,728 26,505Total borrowings $ 233,986 $ 282,583
Schedule Of Future Principal Loan Payments	(Dollars in thousands) Future‎Principal‎Debt Payments2022 $ 33,4872023 123,5622024 43,8732025 3002026 313Thereafter 35,413 Total future principal debt payments $ 236,948